#medical technology #Austria #POLYTECH Health #Dieburg

POLYTECH Health & Aesthetics Expands Direct Operations to Austria

POLYTECH Health & Aesthetics has announced an exciting development in its European operations: as of April 1, 2026, Austria will be its next direct market. This strategic move will transition the company from relying on distributor-led sales to establishing a dedicated local organization, significantly enhancing its commercial footprint and customer engagement in the region.

The initiative is part of a broader strategy to strengthen the company's ties with healthcare professionals, including surgeons and clinics. By establishing direct operations, POLYTECH aims to provide better support through localized services, faster market responsiveness, and a robust framework for professional education. This will enhance their relationships with clinical partners.

Strengthening Local Presence

The decision to expand to Austria marks a pivotal moment for POLYTECH as the company aims to reinforce its local presence in key European markets. CEO Prof. Dr. Karsten Hemmrich commented, "Establishing direct operations in Austria is a crucial step in enhancing our local presence across Europe. Our dedicated country organizations will ensure that we can adequately support surgeons and clinical partners with direct services and a sustained market commitment."

With Austria joining POLYTECH’s Go-Direct model, the company will now operate in multiple countries, including Germany, Italy, France, Israel, and the UK, among others. This expansion is anticipated to create a streamlined approach to market distribution and customer support, facilitating better supply chain management and educational initiatives for professionals in the medical field.

Local Expertise and Continuous Support

To ensure a seamless transition, POLYTECH will capitalize on the established market knowledge and experience of the local team from Bondimed Aesthetics GmbH, which has previously operated in the region. Importantly, Brigitte Kann has been named as the Managing Director for POLYTECH Austria, starting April 1, 2026. She brings over a decade of leadership experience in the medical device sector and is well-versed in the Austrian market.

"Brigitte's extensive background in forming customer partnerships will contribute to a stable and progressive evolution of our local organization," Dr. Hemmrich added. In her new role, Kann expressed her commitment to leveraging local expertise combined with POLYTECH's global capabilities to enhance clinical support and professional training for healthcare practitioners across Austria.

A Vision of Sustainable Partnerships

The transition to direct operations represents a solid foundation for the ongoing growth and development of the Austrian market. POLYTECH is keen to foster sustainable partnerships with local clinics and surgeons by focusing on expert-led education and clinical collaboration. This will establish a network of consistent support and resource availability, which is vital for both healthcare providers and patients.

The approach highlights POLYTECH’s dedication to enhancing local value delivery while emphasizing continuous education and partnership initiatives in the health sector. The company, renowned for its focus on breast aesthetics, reconstruction, and body contouring, has been operational for over 40 years and provides its products to medical professionals in over 90 countries worldwide.

Conclusion

As POLYTECH Health & Aesthetics embarks on this new chapter with the launch of its operations in Austria, stakeholders can expect an era of enhanced service delivery, dedicated support for medical professionals, and a reinforced commitment to patient care. The company’s expansion is not just about growth; it's a strategic move aimed at creating lasting relationships within the healthcare landscape of Austria and beyond.

With this significant development, POLYTECH continues to assert its position as an innovative leader in the medical technology field while focusing on the essential partnership between healthcare providers and industry leaders.